CompanyGraph
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- FinancialsAltman Z-Score 6.07: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.79%Below 5Y avg (0.84%)
Annual Rate
CNY 0.06Paid annual
Payout Ratio
90.9%High
Last Ex-Dividend
Jul 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.57BCNY980.75M · vs all stocks (USD)
Trailing P/E
68.91xvs Biotechnology peers
Revenue (TTM)
778.50MCNY116.25M · vs all stocks (USD)
Profit Margin
10.41%vs Biotechnology peers
Beta
-0.1780xvs all stocks
52-Week Change
-22.32%vs all stocks
Market Capitalization
6.57BCNY980.75M · vs all stocks (USD)
Enterprise Value
5.61BCNY838.02M · vs all stocks (USD)
Trailing P/E
68.91xvs Biotechnology peers
Forward P/E
18.05xvs Biotechnology peers
Price to Sales (TTM)
8.08xvs Biotechnology peers
Price to Book (MRQ)
2.62xvs Biotechnology peers
Enterprise to Revenue
7.21xvs Biotechnology peers
Enterprise to EBITDA
38.53xvs Biotechnology peers
Gross Margin
38.10%vs Biotechnology peers
Profit Margin
10.41%vs Biotechnology peers
Operating Margin
-4.37%vs Biotechnology peers
Return on Assets (TTM)
1.32%vs Biotechnology peers
Return on Equity (TTM)
3.37%vs Biotechnology peers
Revenue (TTM)
778.50MCNY116.25M · vs all stocks (USD)
Revenue per Share (TTM)
0.9830CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-9.30%vs Biotechnology peers
Gross Profit (TTM)
376.54MCNY56.23M · vs all stocks (USD)
EBITDA (TTM)
235.94MCNY35.23M · vs all stocks (USD)
Net Income (TTM)
81.06MCNY12.11M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-53.80%vs Biotechnology peers
Operating Cash Flow (TTM)
68.74MCNY10.27M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-106.24MCNY-15.86M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0640CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.79%vs all stocks
5-Year Average Dividend Yield
0.84%vs all stocks
Payout Ratio
90.91%vs Biotechnology peers
Revenue
792.76MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
368.56MCNYFY2025 · Dec 31, 2025Gross Profit
424.20MCNYFY2025 · Dec 31, 2025Operating Income
138.63MCNY20.70M · vs all stocks (USD)
Pre-tax Income
137.90MCNYFY2025 · Dec 31, 2025Income Tax Expense
7.33MCNYFY2025 · Dec 31, 2025Net Income
130.57MCNYFY2025 · Dec 31, 2025EBIT
145.99MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
235.94MCNYFY2025 · Dec 31, 2025Research & Development
167.89MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
58.70MCNYFY2025 · Dec 31, 2025Other Operating Expenses
10.98MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
23.88MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
8.09MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
816.06MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
816.06MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
130.57MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
129.85MCNYFY2025 · Dec 31, 2025Free Cash Flow
25.52MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.18BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
130.57MCNYFY2025 · Dec 31, 2025Other Non-cash Items
28.70MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-9.12MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-20.29MCNYFY2025 · Dec 31, 2025Capital Expenditures
-104.34MCNYFY2025 · Dec 31, 2025Other Investing Activity
45.91MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-58.42MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
505.18MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-320.36MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-90.62MCNYFY2025 · Dec 31, 2025Other Financing Charges
-43.75MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
50.45MCNYFY2025 · Dec 31, 2025Shares Outstanding
830.30MSharesUpdated Sep 22, 2026Float Shares
372.45MSharesUpdated Sep 22, 2026% Held by Insiders
57.89%vs all stocks
% Held by Institutions
2.68%vs all stocks
Total Cash (MRQ)
1.00BCNY149.91M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.22CNYUpdated Sep 22, 2026Total Debt (MRQ)
361.53MCNY53.99M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1513xvs Biotechnology peers
Current Ratio (MRQ)
2.96xvs Biotechnology peers
Book Value per Share (MRQ)
2.90CNYUpdated Sep 22, 2026Total Assets
3.09BCNY460.72M · vs all stocks (USD)
Total Current Assets
1.82BCNYFY2025 · Dec 31, 2025Total Liabilities
815.89MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.27BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
79.87MCNYFY2025 · Dec 31, 2025Total Current Liabilities
736.02MCNYFY2025 · Dec 31, 2025Cash
1.18BCNYFY2025 · Dec 31, 2025Cash Equivalents
41.55MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.22BCNYFY2025 · Dec 31, 2025Other Short-term Investments
3.94MCNYFY2025 · Dec 31, 2025Accounts Receivable
142.03MCNYFY2025 · Dec 31, 2025Inventory
398.30MCNYFY2025 · Dec 31, 2025Accounts Payable
270.10MCNYFY2025 · Dec 31, 2025Short-term Debt
412.40MCNYFY2025 · Dec 31, 2025Other Current Liabilities
98.29KCNYFY2025 · Dec 31, 2025Long-term Debt
44.25MCNYFY2025 · Dec 31, 2025Common Stock (Book)
830.30MCNYFY2025 · Dec 31, 2025Retained Earnings
903.47MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.27BCNY338.88M · vs all stocks (USD)
Treasury Stock
50.01MCNYFY2025 · Dec 31, 202552-Week Low
7.15CNYUpdated Sep 22, 202652-Week High
10.81CNYUpdated Sep 22, 202652-Week Change
-22.32%vs all stocks
Beta
-0.1780xvs all stocks
50-Day MA
7.89CNYUpdated Sep 22, 2026200-Day MA
9.15CNYUpdated Sep 22, 2026Avg 10-Day Volume
4.30MSharesUpdated Sep 22, 2026Avg 30-Day Volume
7.14MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.1100CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 6.07: safe zoneNotable
Altman Z-Score: 6.07
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Wuhan Huakang Century Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jinghua Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Procept BioRobotics Corporation
Tier 1ProductionApproval-Gated PipelineRule
Corvus Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Frontier Biotechnologies Inc.
Tier 1ProductionApproval-Gated PipelineRule
Suzhou Highfine Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Cisen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Edan Instruments Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Er-Kang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Northeast Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow